Misbah Tahir, Chief Financial Officer at IGM Biosciences, Inc. (IGMS), sold 950 shares at $17.10 ($16K) on 2022-05-26, disclosed to the SEC on 2022-05-26.
Open-market sale of $16k IGMS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| IGMS | SELL | 2025-03-18 | $9K | — | Filing → |
| IGMS | SELL | 2024-12-18 | $13K | — | Filing → |
| IGMS | SELL | 2024-09-17 | $17K | — | Filing → |